International Journal of Hematology

, Volume 93, Issue 3, pp 383–388 | Cite as

Retrospective analysis of paranasal sinusitis in patients receiving hematopoietic stem cell transplantation

  • Young-Woong Won
  • Seong Yoon Yi
  • Jun Ho Jang
  • Kihyun Kim
  • Seok Jin Kim
  • Won Seog Kim
  • Chul Won Jung
  • Dong Hwan Kim
Original Article

Abstract

Hematopoietic stem cell transplantation (HSCT) recipients frequently develop opportunistic infections, including paranasal sinusitis. Paranasal sinusitis in post-transplant recipients can be complicated by life-threatening infections. Accordingly, we analyzed risk factors for development of paranasal sinusitis following HSCT and reviewed our experiences for analysis of the role of management of paranasal sinusitis prior to HSCT. A retrospective review was performed for patients who had received HSCT at Samsung Medical Center (Seoul, South Korea) from 1996 to 2003. A total of 252 patients were analyzed. While 23 patients (9.1%) had sinusitis prior to HSCT, its occurrence rate increased to 15.9% after HSCT. Patients with pre-HSCT sinusitis showed a high occurrence rate of post-HSCT sinusitis (34.8 vs. 14.0%, p = 0.015). However, when pre-HSCT radiological abnormality alone was compared to no evidence of sinusitis prior to HSCT, there was no significant difference in the occurrence rates of post-HSCT sinusitis (15.6 vs. 12.8%, p = 0.541). Although statistical significance was not demonstrated, the occurrence rate of post-HSCT sinusitis was relatively low in patients who received autologous HSCT compared to those who received allogeneic HSCT (11.3 vs. 20.3%, p = 0.060). Use of total body irradiation and presence of graft-versus-host disease did not correlate with development of post-HSCT sinusitis. Compared to the observation group, occurrence of post-HSCT sinusitis showed a slight reduction with medical or surgical intervention targeting radiological abnormalities of the paranasal sinuses (10.0 vs. 25.0%, p = 0.057). In conclusion, pre-HSCT sinusitis and allogeneic HSCT are associated with development of post-HSCT sinusitis. Although asymptomatic radiological abnormalities of the sinus do not increase the risk of post-HSCT sinusitis, optimal treatment prior to HSCT tends to decrease the risk of post-HSCT sinusitis.

Keywords

Paranasal sinusitis Hematopoietic stem cell transplantation Risk factor Treatment 

References

  1. 1.
    Sullivan KM, Mori M, Sanders J, Siadak M, Witherspoon RP, Anasetti C, et al. Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplant. 1992;10(Suppl 1):127–34.PubMedGoogle Scholar
  2. 2.
    Rotstein C, Cummings KM, Tidings J, Killion K, Powell E, Gustafson TL, et al. An outbreak of invasive aspergillosis among allogeneic bone marrow transplants: a case–control study. Infect Control. 1985;6:347–55.PubMedGoogle Scholar
  3. 3.
    Peterson PK, McGlave P, Ramsay NK, Rhame F, Cohen E, Perry GS 3rd, et al. A prospective study of infectious diseases following bone marrow transplantation: emergence of Aspergillus and Cytomegalovirus as the major causes of mortality. Infect Control. 1983;4:81–9.PubMedGoogle Scholar
  4. 4.
    Drakos PE, Nagler A, Or R, Naparstek E, Kapelushnik J, Engelhard D, et al. Invasive fungal sinusitis in patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1993;12:203–8.PubMedGoogle Scholar
  5. 5.
    Yee S, Stern SJ, Hearnsberger HG, Suen JY. Sinusitis in bone marrow transplantation. South Med J. 1994;87:522–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Savage DG, Taylor P, Blackwell J, Chen F, Szydlo RM, Rule SA, et al. Paranasal sinusitis following allogeneic bone marrow transplant. Bone Marrow Transplant. 1997;19:55–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Thompson AM, Couch M, Zahurak ML, Johnson C, Vogelsang GB. Risk factors for post-stem cell transplant sinusitis. Bone Marrow Transplant. 2002;29:257–61.PubMedCrossRefGoogle Scholar
  8. 8.
    Deutsch JH, Hudgins PA, Siegel JL, Peterman SB, Devine SM, York R, et al. The paranasal sinuses of patients with acute graft-versus-host disease. AJNR Am J Neuroradiol. 1995;16:1287–91.PubMedGoogle Scholar
  9. 9.
    Billings KR, Lowe LH, Aquino VM, Biavati MJ. Screening sinus CT scans in pediatric bone marrow transplant patients. Int J Pediatr Otorhinolaryngol. 2000;52:253–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Berlinger NT. Sinusitis in immunodeficient and immunosuppressed patients. Laryngoscope. 1985;95:29–33.PubMedCrossRefGoogle Scholar
  11. 11.
    Shaw G, Panje W, Corey J, Kaminer L, Scher N, Faust R. Risk factors in the development of acute sinusitis in immunocompromised patients. Am J Rhinol. 1991;5:103–8.CrossRefGoogle Scholar
  12. 12.
    Shibuya TY, Momin F, Abella E, Jacobs JR, Karanes C, Ratanatharathorn V, et al. Sinus disease in the bone marrow transplant population: incidence, risk factors, and complications. Otolaryngol Head Neck Surg. 1995;113:705–11.PubMedCrossRefGoogle Scholar
  13. 13.
    Cordonnier C, Gilain L, Ricolfi F, Deforges L, Girard-Pipau F, Poron F, et al. Acquired ciliary abnormalities of nasal mucosa in marrow recipients. Bone Marrow Transplant. 1996;17:611–6.PubMedGoogle Scholar
  14. 14.
    Baldetorp L, Huberman D, Hakansson CH, Toremalm NG. Effects of ionizing radiation on the activity of the ciliated epithelium of the trachea. Acta Radiol Ther Phys Biol. 1976;15:225–32.PubMedGoogle Scholar
  15. 15.
    Albertsson M, Hakansson CH, von Mecklenburg C. Scanning electron microscopy and recording of the physiological activity of tracheal ciliated cells treated by fractionated irradiation. Scan Electron Microsc. 1983;2019–26.Google Scholar
  16. 16.
    Witherspoon RP, Storb R, Ochs HD, Fluornoy N, Kopecky KJ, Sullivan KM, et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood. 1981;58:360–8.PubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2011

Authors and Affiliations

  • Young-Woong Won
    • 1
  • Seong Yoon Yi
    • 2
  • Jun Ho Jang
    • 1
  • Kihyun Kim
    • 1
  • Seok Jin Kim
    • 1
  • Won Seog Kim
    • 1
  • Chul Won Jung
    • 1
  • Dong Hwan Kim
    • 1
  1. 1.Division of Hematology and Oncology, Department of MedicineSamsung Medical Center, Sungkyunkwan University School of MedicineSeoulRepublic of Korea
  2. 2.Department of Internal Medicine,Inje University Ilsan Paik HospitalInje UniversityGoyangSouth Korea

Personalised recommendations